80
Participants
Start Date
December 31, 2013
Primary Completion Date
March 31, 2017
Study Completion Date
February 28, 2018
YPEG-rhG-CSF, 20μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
YPEG-rhG-CSF, 30μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
YPEG-rhG-CSF, 45μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
PEG-rhG-CSF, 100μg/kg, single s.c. at 48hrs after chemotherapy for each experimental cycle
Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou
Shaaxi Provincial Tumor Hospital, Xi'an
Cancer Institute and Hospital, CAMS, Beijing
Fujian cancer hospital, Fuzhou
Fujian Medical University Union Hospital, Fuzhou
Fuzhou General Hospital of Nanjing Military Command, Fuzhou
The First Affiliated Hospital of Guangzhou Medical University, Guangzhou
Shanghai Changzheng Hospital, Shanghai
Shanghai Chest Hospital, Shanghai
Tongji Hospital, Tongji Medical College Huazhou University of Science & Technology, Wuhan
The First Affiliated Hospital of Xiamen University, Xiamen
Zhejiang cancer hospital, Zhejiang
Xiamen Amoytop Biotech Co., Ltd.
INDUSTRY